Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06315218Not ApplicableNot Yet Recruiting

Examining the Health Effects of NPOWER365 Among Black Same Gender Loving Men

Role: collaborator

NCT05376397Not ApplicableCompleted

Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)

Role: collaborator

NCT05415891Not ApplicableUnknown

The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta

Role: collaborator

All 3 trials loaded